Your browser doesn't support javascript.
loading
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Masuda, Takeshi; Miura, Satoru; Sato, Yuki; Tachihara, Motoko; Bessho, Akihiro; Nakamura, Atsushi; Miyawaki, Taichi; Yoshimine, Kohei; Mori, Masahide; Shiraishi, Hideaki; Hamai, Kosuke; Haratani, Koji; Maeda, Sumiko; Tabata, Eriko; Kitagawa, Chiyoe; Tanizaki, Junko; Imai, Takumi; Nogami, Shohei; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Hattori, Noboru.
Affiliation
  • Masuda T; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
  • Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-cho, Niigata, 951-8566, Japan. miusat1118@niigata-cc.jp.
  • Sato Y; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, 650-0047, Japan.
  • Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.
  • Bessho A; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, 700-8607, Japan.
  • Nakamura A; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, 980-0873, Japan.
  • Miyawaki T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shunto-gun, 411-8777, Japan.
  • Yoshimine K; Department of Respiratory Medicine, Iizuka Hospital, Iizuka, 820-8505, Japan.
  • Mori M; Department of Thoracic Oncology, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, 560-8552, Japan.
  • Shiraishi H; Department of Respiratory Medicine, Mitsui Memorial Hospital, Tokyo, 101-8643, Japan.
  • Hamai K; Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, 734-8530, Japan.
  • Haratani K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, 589-8511, Japan.
  • Maeda S; Department of General Thoracic Surgery, Dokkyo Medical University, Shimotsuga-gun, 321-0293, Japan.
  • Tabata E; Department of Respiratory Medicine, Ikeda City Hospital, Ikeda, 563-8510, Japan.
  • Kitagawa C; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, 460-0001, Japan.
  • Tanizaki J; Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, 596-8501, Japan.
  • Imai T; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, 558-8585, Japan.
  • Nogami S; Department of Genome Analysis, LSI Medience Corporation, Tokyo, 174-8555, Japan.
  • Yamamoto N; Department of Internal Medicine III, Wakayama Medical University, Wakayama, 641-8509, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, 589-8511, Japan.
  • Hattori N; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
Sci Rep ; 13(1): 19729, 2023 11 13.
Article in En | MEDLINE | ID: mdl-37957228
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom